Global Induced Pluripotent Stem Cells (iPSCs) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Induced Pluripotent Stem Cells (iPSCs) market size was valued at US$ 99.3 million in 2023. With growing demand in downstream market, the Induced Pluripotent Stem Cells (iPSCs) is forecast to a readjusted size of US$ 230.1 million by 2030 with a CAGR of 12.8% during review period.
The research report highlights the growth potential of the global Induced Pluripotent Stem Cells (iPSCs) market. Induced Pluripotent Stem Cells (iPSCs) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Induced Pluripotent Stem Cells (iPSCs). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Induced Pluripotent Stem Cells (iPSCs) market.
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.
The key players are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL etc. Top 3 companies occupied about 73% market share.
Key Features:
The report on Induced Pluripotent Stem Cells (iPSCs) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Induced Pluripotent Stem Cells (iPSCs) market. It may include historical data, market segmentation by Type (e.g., Human iPSCs, Mouse iPSCs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Induced Pluripotent Stem Cells (iPSCs) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Induced Pluripotent Stem Cells (iPSCs) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Induced Pluripotent Stem Cells (iPSCs) industry. This include advancements in Induced Pluripotent Stem Cells (iPSCs) technology, Induced Pluripotent Stem Cells (iPSCs) new entrants, Induced Pluripotent Stem Cells (iPSCs) new investment, and other innovations that are shaping the future of Induced Pluripotent Stem Cells (iPSCs).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Induced Pluripotent Stem Cells (iPSCs) market. It includes factors influencing customer ' purchasing decisions, preferences for Induced Pluripotent Stem Cells (iPSCs) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Induced Pluripotent Stem Cells (iPSCs) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Induced Pluripotent Stem Cells (iPSCs) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Induced Pluripotent Stem Cells (iPSCs) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Induced Pluripotent Stem Cells (iPSCs) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Induced Pluripotent Stem Cells (iPSCs) market.
Market Segmentation:
Induced Pluripotent Stem Cells (iPSCs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Induced Pluripotent Stem Cells (iPSCs) market size was valued at US$ 99.3 million in 2023. With growing demand in downstream market, the Induced Pluripotent Stem Cells (iPSCs) is forecast to a readjusted size of US$ 230.1 million by 2030 with a CAGR of 12.8% during review period.
The research report highlights the growth potential of the global Induced Pluripotent Stem Cells (iPSCs) market. Induced Pluripotent Stem Cells (iPSCs) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Induced Pluripotent Stem Cells (iPSCs). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Induced Pluripotent Stem Cells (iPSCs) market.
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.
The key players are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL etc. Top 3 companies occupied about 73% market share.
Key Features:
The report on Induced Pluripotent Stem Cells (iPSCs) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Induced Pluripotent Stem Cells (iPSCs) market. It may include historical data, market segmentation by Type (e.g., Human iPSCs, Mouse iPSCs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Induced Pluripotent Stem Cells (iPSCs) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Induced Pluripotent Stem Cells (iPSCs) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Induced Pluripotent Stem Cells (iPSCs) industry. This include advancements in Induced Pluripotent Stem Cells (iPSCs) technology, Induced Pluripotent Stem Cells (iPSCs) new entrants, Induced Pluripotent Stem Cells (iPSCs) new investment, and other innovations that are shaping the future of Induced Pluripotent Stem Cells (iPSCs).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Induced Pluripotent Stem Cells (iPSCs) market. It includes factors influencing customer ' purchasing decisions, preferences for Induced Pluripotent Stem Cells (iPSCs) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Induced Pluripotent Stem Cells (iPSCs) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Induced Pluripotent Stem Cells (iPSCs) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Induced Pluripotent Stem Cells (iPSCs) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Induced Pluripotent Stem Cells (iPSCs) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Induced Pluripotent Stem Cells (iPSCs) market.
Market Segmentation:
Induced Pluripotent Stem Cells (iPSCs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Human iPSCs
- Mouse iPSCs
- Academic Research
- Drug Development and Discovery
- Toxicity Screening
- Regenerative Medicine
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Fujifilm Holding Corporation (CDI)
- Ncardia
- Sumitomo Dainippon Pharma
- Astellas Pharma Inc
- Fate Therapeutics, Inc
- Pluricell Biotech
- Cell Inspire Biotechnology
- ReproCELL
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size 2019-2030
2.1.2 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Induced Pluripotent Stem Cells (iPSCs) Segment by Type
2.2.1 Human iPSCs
2.2.2 Mouse iPSCs
2.3 Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
2.3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
2.4 Induced Pluripotent Stem Cells (iPSCs) Segment by Application
2.4.1 Academic Research
2.4.2 Drug Development and Discovery
2.4.3 Toxicity Screening
2.4.4 Regenerative Medicine
2.4.5 Others
2.5 Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
2.5.1 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
3 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET SIZE BY PLAYER
3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Players
3.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2019-2024)
3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2019-2024)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INDUCED PLURIPOTENT STEM CELLS (IPSCS) BY REGIONS
4.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2019-2024)
4.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2019-2024)
4.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2019-2024)
4.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2019-2024)
4.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024)
5.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024)
5.3 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024)
6.2 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024)
6.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Induced Pluripotent Stem Cells (iPSCs) by Country (2019-2024)
7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024)
7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) by Region (2019-2024)
8.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024)
8.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET FORECAST
10.1 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Regions (2025-2030)
10.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Regions (2025-2030)
10.1.2 Americas Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.3 APAC Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.4 Europe Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2 Americas Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2025-2030)
10.2.1 United States Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.2.2 Canada Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.2.3 Mexico Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.2.4 Brazil Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3 APAC Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2025-2030)
10.3.1 China Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.2 Japan Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.3 Korea Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.4 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.5 India Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.6 Australia Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4 Europe Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2025-2030)
10.4.1 Germany Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.2 France Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.3 UK Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.4 Italy Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.5 Russia Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2025-2030)
10.5.1 Egypt Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.2 South Africa Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.4 Turkey Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.5 GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.6 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Type (2025-2030)
10.7 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Fujifilm Holding Corporation (CDI)
11.1.1 Fujifilm Holding Corporation (CDI) Company Information
11.1.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Fujifilm Holding Corporation (CDI) Main Business Overview
11.1.5 Fujifilm Holding Corporation (CDI) Latest Developments
11.2 Ncardia
11.2.1 Ncardia Company Information
11.2.2 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Ncardia Main Business Overview
11.2.5 Ncardia Latest Developments
11.3 Sumitomo Dainippon Pharma
11.3.1 Sumitomo Dainippon Pharma Company Information
11.3.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sumitomo Dainippon Pharma Main Business Overview
11.3.5 Sumitomo Dainippon Pharma Latest Developments
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Information
11.4.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Astellas Pharma Inc Main Business Overview
11.4.5 Astellas Pharma Inc Latest Developments
11.5 Fate Therapeutics, Inc
11.5.1 Fate Therapeutics, Inc Company Information
11.5.2 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Fate Therapeutics, Inc Main Business Overview
11.5.5 Fate Therapeutics, Inc Latest Developments
11.6 Pluricell Biotech
11.6.1 Pluricell Biotech Company Information
11.6.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pluricell Biotech Main Business Overview
11.6.5 Pluricell Biotech Latest Developments
11.7 Cell Inspire Biotechnology
11.7.1 Cell Inspire Biotechnology Company Information
11.7.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Cell Inspire Biotechnology Main Business Overview
11.7.5 Cell Inspire Biotechnology Latest Developments
11.8 ReproCELL
11.8.1 ReproCELL Company Information
11.8.2 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ReproCELL Main Business Overview
11.8.5 ReproCELL Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size 2019-2030
2.1.2 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Induced Pluripotent Stem Cells (iPSCs) Segment by Type
2.2.1 Human iPSCs
2.2.2 Mouse iPSCs
2.3 Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
2.3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
2.4 Induced Pluripotent Stem Cells (iPSCs) Segment by Application
2.4.1 Academic Research
2.4.2 Drug Development and Discovery
2.4.3 Toxicity Screening
2.4.4 Regenerative Medicine
2.4.5 Others
2.5 Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
2.5.1 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
3 INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET SIZE BY PLAYER
3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Players
3.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2019-2024)
3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2019-2024)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INDUCED PLURIPOTENT STEM CELLS (IPSCS) BY REGIONS
4.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2019-2024)
4.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2019-2024)
4.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2019-2024)
4.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2019-2024)
4.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024)
5.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024)
5.3 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024)
6.2 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024)
6.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Induced Pluripotent Stem Cells (iPSCs) by Country (2019-2024)
7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024)
7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) by Region (2019-2024)
8.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024)
8.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET FORECAST
10.1 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Regions (2025-2030)
10.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Regions (2025-2030)
10.1.2 Americas Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.3 APAC Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.4 Europe Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2 Americas Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2025-2030)
10.2.1 United States Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.2.2 Canada Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.2.3 Mexico Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.2.4 Brazil Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3 APAC Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2025-2030)
10.3.1 China Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.2 Japan Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.3 Korea Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.4 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.5 India Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.6 Australia Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4 Europe Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2025-2030)
10.4.1 Germany Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.2 France Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.3 UK Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.4 Italy Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.4.5 Russia Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2025-2030)
10.5.1 Egypt Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.2 South Africa Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.4 Turkey Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.5.5 GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.6 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Type (2025-2030)
10.7 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Fujifilm Holding Corporation (CDI)
11.1.1 Fujifilm Holding Corporation (CDI) Company Information
11.1.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Fujifilm Holding Corporation (CDI) Main Business Overview
11.1.5 Fujifilm Holding Corporation (CDI) Latest Developments
11.2 Ncardia
11.2.1 Ncardia Company Information
11.2.2 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Ncardia Main Business Overview
11.2.5 Ncardia Latest Developments
11.3 Sumitomo Dainippon Pharma
11.3.1 Sumitomo Dainippon Pharma Company Information
11.3.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sumitomo Dainippon Pharma Main Business Overview
11.3.5 Sumitomo Dainippon Pharma Latest Developments
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Information
11.4.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Astellas Pharma Inc Main Business Overview
11.4.5 Astellas Pharma Inc Latest Developments
11.5 Fate Therapeutics, Inc
11.5.1 Fate Therapeutics, Inc Company Information
11.5.2 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Fate Therapeutics, Inc Main Business Overview
11.5.5 Fate Therapeutics, Inc Latest Developments
11.6 Pluricell Biotech
11.6.1 Pluricell Biotech Company Information
11.6.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pluricell Biotech Main Business Overview
11.6.5 Pluricell Biotech Latest Developments
11.7 Cell Inspire Biotechnology
11.7.1 Cell Inspire Biotechnology Company Information
11.7.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Cell Inspire Biotechnology Main Business Overview
11.7.5 Cell Inspire Biotechnology Latest Developments
11.8 ReproCELL
11.8.1 ReproCELL Company Information
11.8.2 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ReproCELL Main Business Overview
11.8.5 ReproCELL Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Human iPSCs
Table 3. Major Players of Mouse iPSCs
Table 4. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Table 7. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Table 10. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player (2019-2024)
Table 12. Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
Table 13. Induced Pluripotent Stem Cells (iPSCs) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions (2019-2024)
Table 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2019-2024)
Table 22. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Table 24. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Table 26. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2019-2024)
Table 28. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Table 30. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Table 32. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2019-2024)
Table 34. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Table 36. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Induced Pluripotent Stem Cells (iPSCs)
Table 45. Key Market Challenges & Risks of Induced Pluripotent Stem Cells (iPSCs)
Table 46. Key Industry Trends of Induced Pluripotent Stem Cells (iPSCs)
Table 47. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Fujifilm Holding Corporation (CDI) Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 52. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 53. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Fujifilm Holding Corporation (CDI) Main Business
Table 55. Fujifilm Holding Corporation (CDI) Latest Developments
Table 56. Ncardia Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 57. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 58. Ncardia Main Business
Table 59. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Ncardia Latest Developments
Table 61. Sumitomo Dainippon Pharma Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 62. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 63. Sumitomo Dainippon Pharma Main Business
Table 64. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Sumitomo Dainippon Pharma Latest Developments
Table 66. Astellas Pharma Inc Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 67. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 68. Astellas Pharma Inc Main Business
Table 69. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Astellas Pharma Inc Latest Developments
Table 71. Fate Therapeutics, Inc Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 72. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 73. Fate Therapeutics, Inc Main Business
Table 74. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Fate Therapeutics, Inc Latest Developments
Table 76. Pluricell Biotech Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 77. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 78. Pluricell Biotech Main Business
Table 79. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Pluricell Biotech Latest Developments
Table 81. Cell Inspire Biotechnology Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 82. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 83. Cell Inspire Biotechnology Main Business
Table 84. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Cell Inspire Biotechnology Latest Developments
Table 86. ReproCELL Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 87. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 88. ReproCELL Main Business
Table 89. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. ReproCELL Latest Developments
Table 1. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Human iPSCs
Table 3. Major Players of Mouse iPSCs
Table 4. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Table 7. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Table 10. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player (2019-2024)
Table 12. Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
Table 13. Induced Pluripotent Stem Cells (iPSCs) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions (2019-2024)
Table 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2019-2024)
Table 22. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Table 24. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Table 26. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2019-2024)
Table 28. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Table 30. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Table 32. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2019-2024)
Table 34. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Table 36. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Induced Pluripotent Stem Cells (iPSCs)
Table 45. Key Market Challenges & Risks of Induced Pluripotent Stem Cells (iPSCs)
Table 46. Key Industry Trends of Induced Pluripotent Stem Cells (iPSCs)
Table 47. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Fujifilm Holding Corporation (CDI) Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 52. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 53. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Fujifilm Holding Corporation (CDI) Main Business
Table 55. Fujifilm Holding Corporation (CDI) Latest Developments
Table 56. Ncardia Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 57. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 58. Ncardia Main Business
Table 59. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Ncardia Latest Developments
Table 61. Sumitomo Dainippon Pharma Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 62. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 63. Sumitomo Dainippon Pharma Main Business
Table 64. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Sumitomo Dainippon Pharma Latest Developments
Table 66. Astellas Pharma Inc Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 67. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 68. Astellas Pharma Inc Main Business
Table 69. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Astellas Pharma Inc Latest Developments
Table 71. Fate Therapeutics, Inc Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 72. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 73. Fate Therapeutics, Inc Main Business
Table 74. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Fate Therapeutics, Inc Latest Developments
Table 76. Pluricell Biotech Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 77. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 78. Pluricell Biotech Main Business
Table 79. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Pluricell Biotech Latest Developments
Table 81. Cell Inspire Biotechnology Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 82. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 83. Cell Inspire Biotechnology Main Business
Table 84. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Cell Inspire Biotechnology Latest Developments
Table 86. ReproCELL Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 87. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 88. ReproCELL Main Business
Table 89. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. ReproCELL Latest Developments
LIST OF FIGURES
Figure 1. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Induced Pluripotent Stem Cells (iPSCs) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country/Region (2023)
Figure 8. Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2023
Figure 10. Induced Pluripotent Stem Cells (iPSCs) in Academic Research
Figure 11. Global Induced Pluripotent Stem Cells (iPSCs) Market: Academic Research (2019-2024) & ($ Millions)
Figure 12. Induced Pluripotent Stem Cells (iPSCs) in Drug Development and Discovery
Figure 13. Global Induced Pluripotent Stem Cells (iPSCs) Market: Drug Development and Discovery (2019-2024) & ($ Millions)
Figure 14. Induced Pluripotent Stem Cells (iPSCs) in Toxicity Screening
Figure 15. Global Induced Pluripotent Stem Cells (iPSCs) Market: Toxicity Screening (2019-2024) & ($ Millions)
Figure 16. Induced Pluripotent Stem Cells (iPSCs) in Regenerative Medicine
Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Market: Regenerative Medicine (2019-2024) & ($ Millions)
Figure 18. Induced Pluripotent Stem Cells (iPSCs) in Others
Figure 19. Global Induced Pluripotent Stem Cells (iPSCs) Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2023
Figure 21. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player in 2023
Figure 22. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2019-2024 ($ Millions)
Figure 24. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2019-2024 ($ Millions)
Figure 25. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2019-2024 ($ Millions)
Figure 27. Americas Induced Pluripotent Stem Cells (iPSCs) Value Market Share by Country in 2023
Figure 28. United States Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region in 2023
Figure 33. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2023
Figure 34. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2023
Figure 35. China Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country in 2023
Figure 42. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Figure 43. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Figure 44. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 58. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 59. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 61. United States Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 62. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 65. China Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 66. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 67. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 69. India Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 70. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 71. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 72. France Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 73. UK Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 74. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 75. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 76. Spain Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 79. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 82. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Induced Pluripotent Stem Cells (iPSCs) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country/Region (2023)
Figure 8. Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2023
Figure 10. Induced Pluripotent Stem Cells (iPSCs) in Academic Research
Figure 11. Global Induced Pluripotent Stem Cells (iPSCs) Market: Academic Research (2019-2024) & ($ Millions)
Figure 12. Induced Pluripotent Stem Cells (iPSCs) in Drug Development and Discovery
Figure 13. Global Induced Pluripotent Stem Cells (iPSCs) Market: Drug Development and Discovery (2019-2024) & ($ Millions)
Figure 14. Induced Pluripotent Stem Cells (iPSCs) in Toxicity Screening
Figure 15. Global Induced Pluripotent Stem Cells (iPSCs) Market: Toxicity Screening (2019-2024) & ($ Millions)
Figure 16. Induced Pluripotent Stem Cells (iPSCs) in Regenerative Medicine
Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Market: Regenerative Medicine (2019-2024) & ($ Millions)
Figure 18. Induced Pluripotent Stem Cells (iPSCs) in Others
Figure 19. Global Induced Pluripotent Stem Cells (iPSCs) Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2023
Figure 21. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player in 2023
Figure 22. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2019-2024 ($ Millions)
Figure 24. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2019-2024 ($ Millions)
Figure 25. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2019-2024 ($ Millions)
Figure 27. Americas Induced Pluripotent Stem Cells (iPSCs) Value Market Share by Country in 2023
Figure 28. United States Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region in 2023
Figure 33. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2023
Figure 34. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2023
Figure 35. China Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country in 2023
Figure 42. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Figure 43. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Figure 44. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 58. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 59. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 61. United States Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 62. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 65. China Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 66. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 67. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 69. India Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 70. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 71. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 72. France Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 73. UK Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 74. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 75. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 76. Spain Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 79. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Size 2025-2030 ($ Millions)
Figure 82. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Application (2025-2030)
